Administrative Core
行政核心
基本信息
- 批准号:9096639
- 负责人:
- 金额:$ 27.86万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-04-01 至 2021-03-31
- 项目状态:已结题
- 来源:
- 关键词:Advisory CommitteesAntibody ResponseAreaBudgetsCollaborationsCommunicationCommunitiesDataEnsureEquilibriumFosteringGoalsHepatitis C AntibodiesHepatitis C VaccineHepatitis C virusInfectionKnowledgeManuscriptsMonitorPreparationPrimatesProductivityPublicationsReagentResearchResearch ActivityResearch InfrastructureResearch PersonnelResearch Project GrantsSamplingSiteTravelUnited States National Institutes of HealthVaccinationVaccine AntigenVaccinesWorkcost effectivedesignmeetingsmembernonhuman primateoutreachprogramssymposium
项目摘要
PROJECT SUMMARY/ABSTRACT
Developing a broadly effective vaccine against HCV is one of the most important goals in HCV
research. For this program focusing on understand antibody responses elicited in infection and
vaccination and on applying the knowledge to designing HCV vaccine antigens, the Admin Core
is responsible for overseeing and supporting the research activities to accomplish four broad
areas: administrative and fiscal management, communication management, scientific oversight,
and scientific outreach. The Admin Core will provide fiscal oversight, facilitate communication
and reagent sharing between research labs, coordinate sample shipment and storage between
the research sites, monitor scientific progress through internal reviews and the annual scientific
advisory board meeting, coordinate travels of project PIs and researchers to present results in
scientific symposiums and the annual NIH U19 meeting, assist U19 researchers in the
preparation and submission of scientific publications, and organize the annual Scientific
Advisory Committee meeting. The Admin Core will be led by the U19 Center Director with the
help of an Admin Core Manager and an Admin Core Associate to accomplish the above tasks in
a cost-effective manner.
项目概要/摘要
开发广泛有效的 HCV 疫苗是 HCV 领域最重要的目标之一
研究。对于该计划,重点是了解感染和感染中引起的抗体反应
疫苗接种以及应用知识设计 HCV 疫苗抗原,管理核心
负责监督和支持研究活动以实现四大目标
领域:行政和财政管理、沟通管理、科学监督、
和科学推广。管理核心将提供财政监督,促进沟通
研究实验室之间的试剂共享,协调样品之间的运输和存储
研究地点通过内部审查和年度科学报告来监测科学进展
顾问委员会会议,协调项目负责人和研究人员的差旅,以在
科学研讨会和年度 NIH U19 会议,协助 U19 研究人员
编写和提交科学出版物,并组织年度科学会议
咨询委员会会议。管理核心将由 U19 中心主任领导,
在管理核心经理和管理核心助理的帮助下完成上述任务
一种具有成本效益的方式。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Mansun Law其他文献
Mansun Law的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Mansun Law', 18)}}的其他基金
Understanding human antibody responses to chronic viral hepatitis C
了解人类抗体对慢性丙型病毒性肝炎的反应
- 批准号:
10551237 - 财政年份:2022
- 资助金额:
$ 27.86万 - 项目类别:
Understanding human antibody responses to chronic viral hepatitis C
了解人类抗体对慢性丙型病毒性肝炎的反应
- 批准号:
10435356 - 财政年份:2022
- 资助金额:
$ 27.86万 - 项目类别:
Rheumatoid factor and cryoglobulinemia in chronic viral infection
慢性病毒感染中的类风湿因子和冷球蛋白血症
- 批准号:
9896553 - 财政年份:2019
- 资助金额:
$ 27.86万 - 项目类别:
Cooperative Center for the study of HCV antibody responses and vaccine antigens
HCV抗体反应和疫苗抗原研究合作中心
- 批准号:
9248879 - 财政年份:2016
- 资助金额:
$ 27.86万 - 项目类别:
相似海外基金
Characterizing the SARS-CoV-2 antibody response and associations with patient factors: Serological profiling of participants enrolled in the GENCOV study
描述 SARS-CoV-2 抗体反应及其与患者因素的关联:参与 GENCOV 研究的参与者的血清学分析
- 批准号:
495256 - 财政年份:2023
- 资助金额:
$ 27.86万 - 项目类别:
Understanding the human antibody response to a malaria transmission-blocking vaccine
了解人类抗体对疟疾传播阻断疫苗的反应
- 批准号:
MR/X009491/1 - 财政年份:2023
- 资助金额:
$ 27.86万 - 项目类别:
Research Grant
Probing the role of peptidoglycan modification in the antibody response to Staphylococcus aureus
探讨肽聚糖修饰在金黄色葡萄球菌抗体反应中的作用
- 批准号:
10549646 - 财政年份:2023
- 资助金额:
$ 27.86万 - 项目类别:
Identification of the antigenic targets of the clonal antibody response to Clostridioides difficile infection
鉴定针对艰难梭菌感染的克隆抗体反应的抗原靶点
- 批准号:
10742376 - 财政年份:2023
- 资助金额:
$ 27.86万 - 项目类别:
Genetic, structural and functional profiling of the human antibody response to arenavirus infection
人类抗体对沙粒病毒感染反应的遗传、结构和功能分析
- 批准号:
10688292 - 财政年份:2022
- 资助金额:
$ 27.86万 - 项目类别:
Molecular dissection of IgA antibody response by developing monoclonal IgA antibodies from nasal mucosa of mice
通过从小鼠鼻粘膜中开发单克隆 IgA 抗体对 IgA 抗体反应进行分子剖析
- 批准号:
22H02875 - 财政年份:2022
- 资助金额:
$ 27.86万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Mapping the antibody response to Trypanosoma brucei variant surface glycoprotein
绘制布氏锥虫变异表面糖蛋白的抗体反应
- 批准号:
10634694 - 财政年份:2022
- 资助金额:
$ 27.86万 - 项目类别:
Genetic, structural and functional profiling of the human antibody response to arenavirus infection
人类抗体对沙粒病毒感染反应的遗传、结构和功能分析
- 批准号:
10514498 - 财政年份:2022
- 资助金额:
$ 27.86万 - 项目类别:
Mapping the antibody response to Trypanosoma brucei variant surface glycoprotein
绘制布氏锥虫变异表面糖蛋白的抗体反应
- 批准号:
10527979 - 财政年份:2022
- 资助金额:
$ 27.86万 - 项目类别:
Factors related to antibody response of COVID-19 vaccines: with focusing on metabolomics
与 COVID-19 疫苗抗体反应相关的因素:重点关注代谢组学
- 批准号:
22H03334 - 财政年份:2022
- 资助金额:
$ 27.86万 - 项目类别:
Grant-in-Aid for Scientific Research (B)














{{item.name}}会员




